top of page

GATVita - Unlocking the Genetic Puzzle of Pregnancy Loss

Empower Your Medical Practice with GATVita

GATVita is a groundbreaking gene panel, meticulously designed by GATomics to help medical practitioners identify genetic factors contributing to recurrent pregnancy loss in their patients. By leveraging the robustness of Next-Generation Sequencing (NGS) and precision of AI-driven data analysis, GATVita offers clinicians an unprecedented understanding of the genetic basis underlying recurrent pregnancy loss.

Key Features of GATVita:

  • Comprehensive: Analyzes a broad range of genes linked to recurrent pregnancy loss.

  • Precise: Utilizes NGS and AI for accurate genetic interpretation.

  • Improved Patient Outcomes: Allows for early intervention and enhanced patient care.

  • User-Friendly: Delivers clear, actionable reports for physicians..

Key Genes and Associated Conditions in the GATVita Panel

  • MTHFR: Associated with Hyperhomocysteinemia and Neural Tube Defects, which could impact pregnancy outcomes.

  • RNF220: This gene is possibly involved in meiotic recombination, which is crucial for normal gamete formation.

  • MSH4: Mutations in this meiosis-specific protein could impact gametogenesis, potentially affecting fertility.

  • F3 and F5: Variations in these genes can lead to Thrombophilia, a clotting risk that can complicate pregnancy.

  • FSHR: Affects ovarian response to FSH in IVF, with potential implications for fertility treatment outcomes.

  • PROC: Associated with Protein C deficiency, another clotting risk that can complicate pregnancy.

  • MYLK: May affect uterine and vascular smooth muscle function, potentially influencing pregnancy outcomes.

  • FGB, FGA, FGG: These genes are associated with abnormal clotting, a risk factor for complications in pregnancy.

  • HTR1A: Mutations in the serotonin receptor could impact CNS and GI function, potentially affecting mood and digestion during pregnancy.

  • F12, F13A1, F2: Associated with clotting disorders (Factor XII deficiency, Factor XIII deficiency, Prothrombin thrombophilia), which can pose risks during pregnancy.

  • PRL: Abnormal Prolactin levels can impact fertility and pregnancy maintenance.

  • HLA-G: Key role in immunological tolerance in pregnancy, with variations potentially impacting pregnancy outcomes.

  • NEU1, GUSB, FKTN, ALAD, POMT1, ALDH18A1, CBS: These genes are associated with various rare genetic disorders that could potentially impact fetal development and pregnancy outcomes.

  • TSHR: Associated with Congenital hypothyroidism, a condition that can impact the development of the fetus.

  • FBLN5, UBE3A, FBN1, MYH11, NF1, INSR, RPS19, NLRP7: Variations in these genes can lead to a range of conditions that might indirectly affect pregnancy or the health of offspring.

  • SHOX, GATA1, FLNA, IKBKG, F8, SRY: These genes are involved in various syndromes and conditions that could affect fertility, fetal development, and pregnancy outcomes.

Transform Your Patient Care with GATVita

Elevate your practice with GATVita's advanced genetic test for pregnancy-related disorders.

Leave your email:

  • Access GATVita for your patients

  • Stay updated on genetic advancements

Thanks for submitting!

bottom of page